ClinicalTrials.gov: Inflammatory Breast Neoplasms: Open Studies | "Inflammatory Breast Neoplasms" - List Results - ClinicalTrials.gov

Search of: Open Studies | "Inflammatory Breast Neoplasms" - List Results - ClinicalTrials.gov

ClinicalTrials.gov: Inflammatory Breast Neoplasms

06/22/2016 04:29 PM EDT

Source: National Institutes of Health
Related MedlinePlus Page: Breast Cancer

Rank	Status	Study
1	Recruiting	Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer Condition: Inflammatory Breast Cancer Interventions: Biological: Bevacizumab;   Drug: Cyclophosphamide;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Drug: Docetaxel;   Biological: Trastuzumab
2	Recruiting	A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer Conditions: Inflammatory Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Interventions: Drug: Eribulin;   Drug: Adriamycin;   Drug: Cyclophosphamide
3	Recruiting	Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy Condition: Inflammatory Breast Carcinoma Interventions: Drug: 89Zr-bevacizumab;   Procedure: FDG-PET/CT;   Procedure: MRI scan;   Procedure: Tumor biopsies
4	Recruiting	Case-Control Study of Inflammatory Breast Cancer in North Africa Condition: Inflammatory Breast Cancer Intervention:
5	Recruiting	Olaparib and Radiotherapy in Inoperable Breast Cancer Conditions: Locally Advanced Malignant Neoplasm;   Inflammatory Breast Carcinoma;   Triple-Negative Invasive Breast Carcinoma Interventions: Radiation: radiotherapy;   Drug: olaparib
6	Recruiting	Inflammatory Breast Cancer (IBC) Registry Condition: Breast Cancer Interventions: Other: Interview;   Procedure: Blood and Tissue Collection
7	Unknown †	Dose-escalation Study of Oral CX-4945 Conditions: Advanced Solid Tumors;   Breast Cancer;   Inflammatory Breast Cancer;   Castleman's Disease;   Multiple Myeloma Intervention: Drug: CX-4945 oral formulation
8	Recruiting	MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC) Condition: Breast Cancer Interventions: Drug: MK-3475;   Behavioral: Follow Up/Phone Call
9	Recruiting	Nintedanib For HER2-negative Metastatic Inflammatory Breast Cancer (MIBC) Condition: Breast Cancer Interventions: Drug: BIBF 1120;   Behavioral: Phone Call
10	Recruiting	MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer Condition: Breast Cancer Intervention:
11	Not yet recruiting	Denosumab as an add-on Neoadjuvant Treatment (GeparX) Conditions: Breast Cancer Female NOS;   Tubular Breast Cancer Stage II;   Mucinous Breast Cancer Stage II;   Invasive Ductal Breast Cancer;   HER2 Positive Breast Cancer;   Inflammatory Breast Cancer;   Tubular Breast Cancer Stage III Interventions: Drug: Denosumab;   Drug: nab-Paclitaxel;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Carboplatin;   Drug: Trastuzumab;   Drug: Pertuzumab
12	Recruiting	Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive Breast Cancer Patients Conditions: Tubular Breast Cancer;   Mucinous Breast Cancer;   Invasive Ductal Breast Cancer;   Inflammatory Breast Cancer Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Gonadotropin-releasing hormone agonist;   Drug: Letrozole
13	Recruiting	A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) Conditions: Tubular Breast Cancer Stage II;   Tubular Breast Cancer Stage III;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   HER2 Positive Breast Cancer;   Inflammatory Breast Cancer Interventions: Drug: non-pegylated liposomal doxorubicin;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Pertuzumab;   Drug: Trastuzumab;   Drug: Ferric carboxymaltose
14	Recruiting	Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer Conditions: Inflammatory Breast Cancer;   Stage IIA Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-negative Breast Cancer;   Stage IIB Breast Cancer;   Estrogen Receptor Negative;   Progesterone Receptor Negative;   HER2/Neu Negative Interventions: Drug: carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: laboratory biomarker analysis
15	Recruiting	Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer Conditions: HER2-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Breast Adenocarcinoma;   Inflammatory Breast Carcinoma Interventions: Biological: pertuzumab;   Biological: trastuzumab;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: laboratory biomarker analysis
16	Unknown †	"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" Conditions: Infiltrating Duct and Lobular Carcinoma In Situ;   Invasive Lobular Breast Carcinoma;   Inflammatory Breast Carcinoma Intervention: Drug: Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab
17	Not yet recruiting	Talimogene Laherparepvec (T-VEC) for Breast Cancer Local Recurrence Condition: Breast Cancer Interventions: Drug: Talimogene Laherparepvec (T-VEC);   Other: Photographs;   Behavioral: Follow-Up Visit/Phone Call
18	Recruiting	Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa Condition: Breast Cancer Interventions: Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Paclitaxel;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Procedure: Mastectomy;   Radiation: Radiation Therapy
19	Unknown †	Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer Conditions: Breast Cancer;   Cardiac Toxicity;   Perioperative/Postoperative Complications Interventions: Biological: bevacizumab;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Procedure: assessment of therapy complications;   Procedure: neoadjuvant therapy;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
20	Unknown †	Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer Condition: Breast Cancer Interventions: Drug: capecitabine;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Procedure: neoadjuvant therapy